Weight-Loss Drug Popularity Spurs Demand for Facial Treatments and Supplements
The rising popularity of GLP-1 weight-loss drugs like Ozempic and Wegovy has led to increased demand for treatments addressing side effects such as facial sagging and gastrointestinal issues. Beauty firms including Galderma, Natura, and L'Oreal are developing solutions for 'Ozempic face,' linked to rapid weight loss rather than the drugs themselves. Concurrently, many users turn to dietary supplements to manage side effects, raising concerns among doctors and regulators about their unregulated nature and efficacy.
First-hand measurement across 3 sources
We measured how 3 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (53/100). Lens Score 52/100.
Outlets measured: economictimes, economictimes, economictimes. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (52–55/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
economictimes broke this story on 20 Oct, 07:17 am. Other outlets followed.